(FRAG (NP (NN Objective)) (: :) (S (NP (NN Reproducibility)) (VP (VBZ is) (NP (NP (DT a) (NN core) (NN tenet)) (PP (IN of) (NP (JJ scientific) (NN research)))))) (. .))
(S (NP (DT A) (JJ reproducible) (NN study)) (VP (VBZ is) (NP (NP (CD one)) (SBAR (WHADVP (WRB where)) (S (NP (DT the) (NNS results)) (VP (MD can) (VP (VB be) (VP (VBN recreated) (PP (IN by) (NP (NP (JJ different) (NNS investigators)) (PP (IN in) (NP (JJ different) (NNS circumstances))))) (S (VP (VBG using) (NP (NP (DT the) (JJ same) (NN methodology)) (CC and) (NP (NNS materials)))))))))))) (. .))
(S (ADVP (RB Unfortunately)) (, ,) (NP (NN reproducibility)) (VP (VBZ is) (RB not) (NP (NP (DT a) (JJ standard)) (SBAR (WHPP (TO to) (WHNP (WDT which))) (S (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (NN research)))) (VP (VBZ is) (ADVP (RB currently)) (NP (NN adherent))))))) (. .))
(FRAG (NP (NNS Methods)) (: :) (S (NP (PRP We)) (ADVP (RB objectively)) (VP (VBD evaluated) (NP (CD 300) (NNS trials)) (PP (IN in) (NP (NP (DT the) (NN field)) (PP (IN of) (NP (NNP Obstetrics) (CC and) (NNP Gynecology))))) (PP (IN for) (NP (NP (CD fourteen) (NNS indicators)) (PP (IN of) (NP (NN reproducibility))))))) (. .))
(S (NP (DT These) (NNS indicators)) (VP (VBP include) (UCP (NP (NP (NN availability)) (PP (IN of) (NP (NNS data))) (, ,) (NP (NN analysis) (NNS scripts)) (, ,) (NP (JJ pre-registration) (NN information)) (, ,) (NP (NN study) (NNS protocols))) (CC and) (SBAR (IN whether) (CC or) (RB not) (S (NP (DT the) (NN study)) (VP (VBD was) (ADJP (JJ available) (PP (IN via) (NP (NNP Open) (NNP Access))))))))) (. .))
(S (NP (PRP We)) (ADVP (RB also)) (VP (VBD assessed) (NP (DT the) (NNS trials)) (PP (IN for) (NP (NP (NP (JJ financial) (NN conflict)) (PP (IN of) (NP (NN interest) (NNS statements)))) (CC and) (NP (NP (NN source)) (PP (IN of) (NP (NN funding))))))) (. .))
(FRAG (NP (NNS Results)) (: :) (S (PP (IN Of) (NP (NP (DT the) (CD 300) (NNS trials)) (PP (IN in) (NP (PRP$ our) (NN sample))))) (, ,) (NP (CD 208)) (VP (VBD contained) (NP (NP (JJ empirical) (NNS data)) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VB be) (VP (VBN assessed) (PP (IN for) (NP (NN reproducibility))))))))))) (. .))
(S (NP (NP (NN None)) (PP (IN of) (NP (NP (DT the) (NNS trials)) (PP (IN in) (NP (PRP$ our) (NN sample)))))) (VP (VP (VBD provided) (NP (DT a) (NN link)) (PP (IN to) (NP (PRP$ their) (NNS protocols)))) (CC or) (VP (VBN provided) (NP (DT a) (NN statement)) (PP (IN on) (NP (NP (NN availability)) (PP (IN of) (NP (NNS materials))))))) (. .))
(S (NP (NN None)) (VP (VBD were) (NP (NN replication) (NNS studies))) (. .))
(S (NP (QP (RB Just) (CD 10.58)) (NN %)) (VP (VBD provided) (NP (NP (DT a) (NN statement)) (PP (VBG regarding) (NP (NP (PRP$ their) (NNS data) (NN availability)) (, ,) (SBAR (IN while) (S (NP (QP (RB only) (CD 5.82)) (NN %)) (VP (VBD provided) (NP (DT a) (NN statement)) (PP (IN on) (NP (NN preregistration)))))))))) (. .))
(S (S (NP (CD 25.85) (NN %)) (VP (VBD failed) (S (VP (TO to) (VP (VB report) (NP (NP (DT the) (NN presence) (CC or) (NN absence)) (PP (IN of) (NP (NP (NNS conflicts)) (PP (IN of) (NP (NN interest))))))))))) (CC and) (S (NP (CD 54.08) (NN %)) (VP (VBD did) (RB not) (VP (VB state) (NP (NP (DT the) (NN origin)) (PP (IN of) (NP (PRP$ their) (NN funding))))))) (. .))
(FRAG (NP (NN Conclusion)) (: :) (S (NP (NP (NN Research)) (PP (IN in) (NP (NP (DT the) (NN field)) (PP (IN of) (NP (NNS Obstetrics) (CC and) (NN Gynecology)))))) (VP (VP (VBZ is) (RB not) (ADJP (RB consistently) (JJ reproducible))) (CC and) (ADVP (RB frequently)) (VP (VBZ lacks) (NP (NP (NN conflict)) (PP (IN of) (NP (NN interest) (NN disclosure))))))) (. .))
(S (NP (NP (NNS Consequences)) (PP (IN of) (NP (DT this)))) (VP (VP (MD could) (VP (VB be) (ADJP (RB far) (HYPH -) (VBG reaching)))) (CC and) (VP (VBP include) (NP (NP (VBN increased) (NN research) (NN waste)) (, ,) (NP (NP (JJ widespread) (NN acceptance)) (PP (IN of) (NP (JJ misleading) (NNS results)))) (CC and) (NP (NP (JJ erroneous) (NNS conclusions)) (VP (VBG guiding) (NP (JJ clinical) (NN decision) (HYPH -) (NN making))))))) (. .))
